Pulmatrix Inc stock is traded at $1.35, with a volume of 9,342. It is down -0.37% in the last 24 hours and down -7.53% over the past month. Pulmatrix Inc is a biopharmaceutical company focused on the development of novel inhaled therapeutic products intended to prevent and treat migraine and respiratory diseases with important unmet medical needs using its patented dry powder delivery technology, iSPERSE. Its pipeline of clinical assets includes PUR3100 for the treatment of acute migraine, PUR1800 for the treatment of acute exacerbations of chronic obstructive pulmonary disease (AECOPD), and PUR1900 for the treatment of ABPA in patients with asthma and in patients with cystic fibrosis (CF).
Previous Close:
$1.36
Open:
$1.30
24h Volume:
9,342
Relative Volume:
0.20
Market Cap:
$4.93M
Revenue:
$3,000
Net Income/Loss:
-$4.53M
P/E Ratio:
-
EPS:
-$1.24
Net Cash Flow:
-$4.69M
1W Performance:
+1.50%
1M Performance:
-7.53%
6M Performance:
+4.08%
1Y Performance:
-72.05%
1-Day Range:
$1.30$1.42
1-Week Range:
$1.06$1.54
52-Week Range:
$1.06$4.98
Pulmatrix Inc Stock (PULM) Company Profile
Name
Pulmatrix IncSector
HealthcareIndustry
BiotechnologyPhone
(888) 355-4440Address
945 CONCORD STREET, FRAMINGHAM, MA, USAMarket Cap
Revenue
Net Income
Cash Flow
EPS